Showing 1 - 10 of 11
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10003480016
Persistent link: https://www.econbiz.de/10003654977
Persistent link: https://www.econbiz.de/10001860150
Persistent link: https://www.econbiz.de/10000420226
Persistent link: https://www.econbiz.de/10002774930
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10012776880
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10012465529
Persistent link: https://www.econbiz.de/10005293365
Persistent link: https://www.econbiz.de/10007742690
End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...
Persistent link: https://www.econbiz.de/10005830628